2 completed. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow fitusiran: new trials by email Literature Review of fitusiran trials Research Report on fitusiran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B Fitusiran - Hemophilia | Phase 2 / Phase 3 | Completed | Genzyme, a Sanofi Company | 32 | 2020-01-28 | 2026-09-28 |
| An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B Fitusiran (SAR439774) - Hemophilia A, Hemophilia B | Phase 1 / Phase 2 | Completed | Genzyme, a Sanofi Company | 34 | 2015-09-18 | 2024-06-05 |
Hemophilia A (2) · Hemophilia B (1)
United States (2) · Bulgaria (1) · Canada (1) · India (1) · Italy (1) · Russia (1) · Spain (1) · Switzerland (1) · Turkey (Türkiye) (1) · United Kingdom (1)
2015 (1), 2019 (1)